Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Update

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a large drop in short interest in April. As of April 30th, there was short interest totaling 7,692 shares, a drop of 63.5% from the April 15th total of 21,047 shares. Based on an average daily volume of 4,461 shares, the days-to-cover ratio is currently 1.7 days.

Relief Therapeutics Price Performance

OTCMKTS RLFTF remained flat at $0.50 during mid-day trading on Thursday. The company’s stock had a trading volume of 2,298 shares, compared to its average volume of 3,475. Relief Therapeutics has a 12-month low of $0.33 and a 12-month high of $4.88. The firm’s fifty day simple moving average is $0.50 and its two-hundred day simple moving average is $1.81.

Relief Therapeutics Company Profile

Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.

The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.